Literature DB >> 22891176

Gluten-free diet does not appear to induce endoscopic remission of eosinophilic esophagitis in children with coexistent celiac disease.

Joseph R Abraham1, Rabin Persad, Justine M Turner, Hien Q Huynh.   

Abstract

BACKGROUND: Celiac disease and eosinophilic esophagitis are usually considered to be separate gastrointestinal diseases; however, it appears that they may coexist more often than would be expected. It is unknown whether eosinophilic esophagitis in patients with celiac disease responds to a gluten-free diet.
OBJECTIVES: To examine the clinical, endoscopic and histological features of children with both conditions to evaluate whether eosinophilic esophagitis responds to a gluten-free diet.
METHODS: From January 1, 2009, to June 30, 2011, the medical records of children <18 years of age diagnosed with eosinophilic esophagitis and⁄or celiac disease were reviewed. Patients with clinical, endoscopic and histological diagnoses of both diseases were identified and included. These findings were analyzed, as were laboratory results, treatment and follow-up.
RESULTS: During the study period, there were 206 celiac disease patients, 86 eosinophilic esophagitis patients and nine (4.4% of total celiac) patients with both diagnoses. Gluten-free diet was the primary treatment for both conditions in seven of nine (78%) cases. In six of these seven (86%) patients, no endoscopic or histological improvement of eosinophilic esophagitis was observed, while in one patient, histological remission of esophageal eosinophilia occurred while on a gluten-free diet.
CONCLUSION: The prevalence of eosinophilic esophagitis in patients with celiac disease was 4.4%, confirming a higher than expected prevalence of eosinophilic esophagitis compared with the general population. In patients with celiac disease, a gluten-free diet did not appear to induce remission of coexistent endoscopic and histological features of eosinophilic esophagitis.

Entities:  

Mesh:

Year:  2012        PMID: 22891176      PMCID: PMC3414473          DOI: 10.1155/2012/159257

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  15 in total

1.  Prevalence of asymptomatic celiac disease in adolescents of eastern Switzerland.

Authors:  Regula Rutz; Eva Ritzler; Walter Fierz; Denise Herzog
Journal:  Swiss Med Wkly       Date:  2002-01-26       Impact factor: 2.193

2.  Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data.

Authors:  C R Simpson; W J A Anderson; P J Helms; M W Taylor; L Watson; G J Prescott; D J Godden; R N Barker
Journal:  Clin Exp Allergy       Date:  2002-01       Impact factor: 5.018

3.  Eosinophilic esophagitis.

Authors:  Richard J Noel; Philip E Putnam; Marc E Rothenberg
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

Review 4.  Clinical guidelines for celiac disease in children: what does it mean to the pediatrician/family practitioner?

Authors:  Shailender Madani; Deepak Kamat
Journal:  Clin Pediatr (Phila)       Date:  2006-04       Impact factor: 1.168

Review 5.  Clinical features and diagnosis of celiac disease.

Authors:  David H Dewar; Paul J Ciclitira
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

6.  The changing frequency of celiac disease diagnosed at the Stollery Children's Hospital.

Authors:  Seema Rajani; Hien Q Huynh; Justine Turner
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

7.  Clinical presentation of celiac disease and the diagnostic accuracy of serologic markers in children.

Authors:  Eberhard Lurz; Ursina Scheidegger; Johannes Spalinger; Martin Schöni; Susanne Schibli
Journal:  Eur J Pediatr       Date:  2008-10-16       Impact factor: 3.183

8.  Eosinophilic esophagitis in children with celiac disease.

Authors:  Chee Y Ooi; Andrew S Day; Reuben Jackson; Tim D Bohane; Vivienne Tobias; Daniel A Lemberg
Journal:  J Gastroenterol Hepatol       Date:  2007-12-07       Impact factor: 4.029

Review 9.  Investigation and management of coeliac disease.

Authors:  A F Rodrigues; H R Jenkins
Journal:  Arch Dis Child       Date:  2007-09-19       Impact factor: 3.791

10.  Eosinophilic oesophagitis and coeliac disease: is there an association?

Authors:  L Quaglietta; P Coccorullo; E Miele; F Pascarella; R Troncone; A Staiano
Journal:  Aliment Pharmacol Ther       Date:  2007-08-01       Impact factor: 8.171

View more
  6 in total

1.  Increased Risk of Esophageal Eosinophilia and Eosinophilic Esophagitis in Patients With Active Celiac Disease on Biopsy.

Authors:  Elizabeth T Jensen; Swathi Eluri; Benjamin Lebwohl; Robert M Genta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-24       Impact factor: 11.382

2.  Eosinophilic esophagitis--recognition, diet and drugs.

Authors:  Marietta Iacucci; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-08       Impact factor: 3.522

3.  Mucosal inflammation, esophageal eosinophilia, and celiac disease: a little "pinch" will have to do you.

Authors:  Calies Menard-Katcher; Glenn T Furuta; Joanne C Masterson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-04       Impact factor: 2.839

4.  Emerging therapeutic options for eosinophilic esophagitis.

Authors:  Timothy Dougherty; Sindu Stephen; Marie L Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-02

5.  Eosinophilic esophagitis associated with celiac disease in children.

Authors:  Rajmohan Dharmaraj; Karen Hagglund; Hernando Lyons
Journal:  BMC Res Notes       Date:  2015-06-26

6.  Esophageal Eosinophilia and Eosinophilic Esophagitis in Celiac Children: A Ten Year Prospective Observational Study.

Authors:  Fernanda Cristofori; Fulvio Salvatore D'Abramo; Vincenzo Rutigliano; Vanessa Nadia Dargenio; Stefania Castellaneta; Domenico Piscitelli; Davide De Benedittis; Flavia Indrio; Lidia Celeste Raguseo; Michele Barone; Ruggiero Francavilla
Journal:  Nutrients       Date:  2021-10-24       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.